VisMederi Holding

Improving human health

Vismederi Holding

Vismederi Holding is the company that holds a qualified share of the companies that are part of the VisMederi Group. The Group of Vismederi Holding operates in various business areas all related to Research and Innovation in the fields of Public Health, Life Sciences and Biotechnologies and is composed of VisMederi Srl, VisMederi Research Srl, VisMederi Life Sciences Srl, VisMederi Textyle Srl, VisMederi Pharma Srl, ETHS – Education and Training for Health Sciences Srl with single shareholder, Accurange Srl.

Vismederi Holding
0Mln €

Revenues

0

Employees 

0Paesi

Global Partnerships

Vismederi Holding: latest news

All the news of the group

Oct 08 2024

The first workshop involving Trialect and the Vismederi Foundation is underway!

For those wishing to fully immerse themselves in the serological techniques required by regulatory agencies including the FDA, EMA, and PMD for the...
Sep 30 2024

VisMederi Foundation at the Bright-Night 2024

European Night of Female Researchers and Scientists in Tuscany is known as Bright Night. Whether geographic, historical, artistic, literary,...
Sep 27 2024

VisMederi will be present at the World Vaccine Congress Europe 2024 in Barcelona

VisMederi will be attending the World Vaccine Congress Europe 2024, taking place from October 28th to 31st at Fira de Barcelona, Montjuïc. The...
Sep 24 2024

Collaboration Agreement Signed Between Trialect Inc. USA and Fondazione VisMederi

Fondazione VisMederi has signed an agreement with Trialect Inc., USA, for the program entitled “Trialect Global Medical Education Program.” This...
Aug 23 2024

A new study suggests that antibodies produced by vaccinia-based vaccines may neutralize the Monkeypox virus

A new study suggests that antibodies produced by vaccinia-based vaccines may neutralize the Monkeypox virus, suggesting potential cross-protection...
Aug 07 2024

VisMederi has been successfully qualified by Qualifyze for conducting activities according to GCLP

VisMederi has been successfully qualified by Qualifyze for conducting activities according to GCLP (Good Clinical Laboratory Practices). Both our...
Jun 12 2024

Important international study in the field of Monkey Pox and Vaccinia Virus

Another important international study in the field of Monkey Pox and Vaccinia Virus: a sero-epidemiological study assessing the neutralizing...
Jun 04 2024

Students from Kent State University visit VisMederi

At the heart of research and innovation, the Vismederi Foundation warmly welcomed a group of American students from Kent State University at the...
May 22 2024

VIII International Conference and Exhibition IVW 2024 in Siena

The eighth edition of the "Influenza Vaccines for the World—IVW 2024" conference and exhibition is currently taking place in Siena (May 21–23,...
May 10 2024

VisMederi and the International Vaccine Institute have formed a new partnership to accelerate vaccine development in developing countries.

VisMederi and the International Vaccine Institute have formed a new partnership to accelerate vaccine development in developing countries....

Where we

are

 

 

 

 

 

 

The

founder

Emanuele Montomoli is Full Professor of Hygiene and Public Health at the University of Siena, Italy. He received his BSc and MSc in Life Sciences from the University of Siena, Italy in 1997 and he earned his MBiochem in 2001.